We’ve refreshed our website! Take a look around, tell us what you think, or revisit the archived site.
Save the Date: Join us April 28 - May 2 for the 2027 MDF International Conference in Seattle, Washington!
IMPORTANT: Find all anesthesia guides for individuals and their families and healthcare professionals

Considerations & Open Discussions of Exercise Impact on Clinical Trials & Everyday Health – 2022 MDF Annual Conference

Published: November 3, 2022

Presented on September 9, 2022.

Presented by Thomas A. Cooper, MD, Mark Tarnopolsky, MD, PhD, FRCP(C), Elise Duchesne, PhD, Andrew Berglund, PhD, and Tina Duong MPT, PhD

The Professional Track begins with a session on DM and exercise. Thomas A. Cooper, MD, presents, Endurance exercise leads to beneficial molecular and physiological effects in the HSALR mouse model of myotonic dystrophy type 1. Mark Tarnopolsky, MD, PhD, FRCP(C) presents, Exercise and nutritional strategies for myotonic dystrophy. After a short break, Elise Duchesne, PhD, presents, Strength training effectively alleviates skeletal muscle impairments in myotonic dystrophy type 1. Andrew Berglund, PhD., presents, the Analysis of individual transcriptomic response to strength training for myotonic dystrophy type 1 patients reveals rescue at the molecular level. The session will end with a presentation by Tina Duong MPT, PhD.

Click here to learn more about the 2022 MDF Annual Conference.

Featured in this video

Mark Tarnopolsky, MD, PhD, FRCPC

Clinic: Depts of Pediatrics and Medicine, McMaster University Medical Centre

Specialties: Pediatrics